{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:37:46Z","timestamp":1791959866482,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T00:00:00Z","timestamp":1369785600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2377-13-54","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T08:15:04Z","timestamp":1369815304000},"source":"Crossref","is-referenced-by-count":115,"title":["Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia"],"prefix":"10.1186","volume":"13","author":[{"given":"Maria","family":"Landqvist Wald\u00f6","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Frizell Santillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Passant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,29]]},"reference":[{"issue":"6","key":"777_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998, 51 (6): 1546-1554. 10.1212\/WNL.51.6.1546.","journal-title":"Neurology"},{"issue":"1","key":"777_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1750-3639.2007.00055.x","volume":"17","author":"S Kumar-Singh","year":"2007","unstructured":"Kumar-Singh S, Van Broeckhoven C: Frontotemporal lobar degeneration: current concepts in the light of recent advances. Brain Pathol. 2007, 17 (1): 104-114. 10.1111\/j.1750-3639.2007.00055.x.","journal-title":"Brain Pathol"},{"issue":"5796","key":"777_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006, 314 (5796): 130-133. 10.1126\/science.1134108.","journal-title":"Science"},{"issue":"5","key":"777_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00401-009-0581-5","volume":"118","author":"M Neumann","year":"2009","unstructured":"Neumann M, Roeber S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IR: Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol. 2009, 118 (5): 605-616. 10.1007\/s00401-009-0581-5.","journal-title":"Acta Neuropathol"},{"issue":"Pt 11","key":"777_CR5","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/brain\/awp214","volume":"132","author":"M Neumann","year":"2009","unstructured":"Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR: A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain. 2009, 132 (Pt 11): 2922-2931.","journal-title":"Brain"},{"issue":"3","key":"777_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s12031-011-9551-1","volume":"45","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie IR, Neumann M, Cairns NJ, Munoz DG, Isaacs AM: Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43. J Mol Neurosci. 2011, 45 (3): 402-408. 10.1007\/s12031-011-9551-1.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"777_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00401-010-0698-6","volume":"120","author":"H Urwin","year":"2010","unstructured":"Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, Seelaar H, Van Swieten JC, Brown JM, Johannsen P: FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010, 120 (1): 33-41. 10.1007\/s00401-010-0698-6.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"777_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","volume":"122","author":"KA Josephs","year":"2011","unstructured":"Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, Dickson DW: Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011, 122 (2): 137-153. 10.1007\/s00401-011-0839-6.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"777_CR9","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/nm.2221","volume":"16","author":"K Blennow","year":"2010","unstructured":"Blennow K: Biomarkers in Alzheimer\u2019s disease drug development. Nat Med. 2010, 16 (11): 1218-1222. 10.1038\/nm.2221.","journal-title":"Nat Med"},{"issue":"1","key":"777_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","volume":"117","author":"T Kasai","year":"2009","unstructured":"Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, Mann DM, Allsop D, Nakagawa M: Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2009, 117 (1): 55-62. 10.1007\/s00401-008-0456-1.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"777_CR11","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","volume":"67","author":"LE Rosengren","year":"1996","unstructured":"Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C: Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem. 1996, 67 (5): 2013-2018.","journal-title":"J Neurochem"},{"issue":"1","key":"777_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","volume":"987","author":"N Norgren","year":"2003","unstructured":"Norgren N, Rosengren L, Stigbrand T: Elevated neurofilament levels in neurological diseases. Brain Res. 2003, 987 (1): 25-31. 10.1016\/S0006-8993(03)03219-0.","journal-title":"Brain Res"},{"issue":"1","key":"777_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.parkreldis.2011.08.012","volume":"18","author":"S Bech","year":"2012","unstructured":"Bech S, Hjermind LE, Salvesen L, Nielsen JE, Heegaard NH, Jorgensen HL, Rosengren L, Blennow K, Zetterberg H, Winge K: Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes. Parkinsonism Relat Disord. 2012, 18 (1): 69-72. 10.1016\/j.parkreldis.2011.08.012.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"777_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jnr.1242","volume":"66","author":"M Sjogren","year":"2001","unstructured":"Sjogren M, Blomberg M, Jonsson M, Wahlund LO, Edman A, Lind K, Rosengren L, Blennow K, Wallin A: Neurofilament protein in cerebrospinal fluid: a marker of white matter changes. J Neurosci Res. 2001, 66 (3): 510-516. 10.1002\/jnr.1242.","journal-title":"J Neurosci Res"},{"key":"777_CR15","first-page":"135","volume-title":"Vascular cognitive impairment","author":"FEE Fazekas","year":"2002","unstructured":"Fazekas FEE: White matter lesions. Vascular cognitive impairment. Edited by: Erkinjuntti TGS. 2002, London: Martin Dunitz, 135-143."},{"issue":"3","key":"777_CR16","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.neuroimage.2012.01.106","volume":"60","author":"E Rostrup","year":"2012","unstructured":"Rostrup E, Gouw AA, Vrenken H, van Straaten EC, Ropele S, Pantoni L, Inzitari D, Barkhof F, Waldemar G: The spatial distribution of age-related white matter changes as a function of vascular risk factors\u2013results from the LADIS study. NeuroImage. 2012, 60 (3): 1597-1607. 10.1016\/j.neuroimage.2012.01.106.","journal-title":"NeuroImage"},{"issue":"2\u20133","key":"777_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000101843","volume":"4","author":"A Petzold","year":"2007","unstructured":"Petzold A, Keir G, Warren J, Fox N, Rossor MN: A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia. Neurodegener Dis. 2007, 4 (2\u20133): 185-194.","journal-title":"Neurodegener Dis"},{"issue":"9","key":"777_CR18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/jnnp.2006.107326","volume":"78","author":"D de Jong","year":"2007","unstructured":"de Jong D, Jansen RW, Pijnenburg YA, van Geel WJ, Borm GF, Kremer HP, Verbeek MM: CSF neurofilament proteins in the differential diagnosis of dementia. J Neurol Neurosurg Psychiatry. 2007, 78 (9): 936-938. 10.1136\/jnnp.2006.107326.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"777_CR19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/j.1468-1331.2007.01972.x","volume":"14","author":"H Zetterberg","year":"2007","unstructured":"Zetterberg H, Jacobsson J, Rosengren L, Blennow K, Andersen PM: Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype. Eur J Neurol. 2007, 14 (12): 1329-1333. 10.1111\/j.1468-1331.2007.01972.x.","journal-title":"Eur J Neurol"},{"issue":"4","key":"777_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1468-1331.2009.02853.x","volume":"17","author":"L Fialova","year":"2010","unstructured":"Fialova L, Svarcova J, Bartos A, Ridzon P, Malbohan I, Keller O, Rusina R: Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis. European journal of neurology: the official journal of the European Federation of Neurological Societies. 2010, 17 (4): 562-566. 10.1111\/j.1468-1331.2009.02853.x.","journal-title":"European journal of neurology: the official journal of the European Federation of Neurological Societies"},{"issue":"Pt 9","key":"777_CR21","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU: Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain: a journal of neurology. 2011, 134 (Pt 9): 2456-2477.","journal-title":"Brain: a journal of neurology"},{"issue":"7","key":"777_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984, 34 (7): 939-944. 10.1212\/WNL.34.7.939.","journal-title":"Neurology"},{"issue":"5","key":"777_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/00365517709091496","volume":"37","author":"G Tibbling","year":"1977","unstructured":"Tibbling G, Link H, Ohman S: Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977, 37 (5): 385-390. 10.3109\/00365517709091496.","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"777_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E: Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol Chem Neuropathol. 1995, 26 (3): 231-245. 10.1007\/BF02815140.","journal-title":"Mol Chem Neuropathol"},{"issue":"1","key":"777_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E Vanmechelen","year":"2000","unstructured":"Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B, Sjogren M, Andreasen N, Blennow K: Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett. 2000, 285 (1): 49-52. 10.1016\/S0304-3940(00)01036-3.","journal-title":"Neurosci Lett"},{"issue":"6","key":"777_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K: Cerebrospinal fluid beta-amyloid(1\u201342) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol. 1999, 56 (6): 673-680. 10.1001\/archneur.56.6.673.","journal-title":"Arch Neurol"},{"issue":"8","key":"777_CR27","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/JGP.0b013e3181a6516e","volume":"17","author":"H Brunnstrom","year":"2009","unstructured":"Brunnstrom H, Englund E: Clinicopathological concordance in dementia diagnostics. Am J Geriatr Psychiatry. 2009, 17 (8): 664-670. 10.1097\/JGP.0b013e3181a6516e.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"777_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0167-4943(87)90021-5","volume":"6","author":"A Brun","year":"1987","unstructured":"Brun A: Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr. 1987, 6 (3): 193-208. 10.1016\/0167-4943(87)90021-5.","journal-title":"Arch Gerontol Geriatr"},{"issue":"6","key":"777_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-004-0917-0","volume":"108","author":"C Kersaitis","year":"2004","unstructured":"Kersaitis C, Halliday GM, Kril JJ: Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol. 2004, 108 (6): 515-523. 10.1007\/s00401-004-0917-0.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"777_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF: Classification of primary progressive aphasia and its variants. Neurology. 2011, 76 (11): 1006-1014. 10.1212\/WNL.0b013e31821103e6.","journal-title":"Neurology"},{"issue":"1","key":"777_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mds.870130116","volume":"13","author":"B Holmberg","year":"1998","unstructured":"Holmberg B, Rosengren L, Karlsson JE, Johnels B: Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson\u2019s disease. Movement disorders: official journal of the Movement Disorder Society. 1998, 13 (1): 70-77. 10.1002\/mds.870130116.","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"4","key":"777_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000099473","volume":"23","author":"YA Pijnenburg","year":"2007","unstructured":"Pijnenburg YA, Janssen JC, Schoonenboom NS, Petzold A, Mulder C, Stigbrand T, Norgren N, Heijst H, Hack CE, Scheltens P: CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer\u2019s disease and controls. Dement Geriatr Cogn Disord. 2007, 23 (4): 225-230. 10.1159\/000099473.","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-13-54.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-13-54\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-13-54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T20:57:23Z","timestamp":1468270643000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-13-54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,29]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-13-54","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,29]]},"article-number":"54"}}